NASHUA, N.H., March 02, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it is ...
Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA "iCAD is committed to developing the most comprehensive, ...
RadNet's acquisition of iCAD offers strong innovation synergies, a high control premium, and minimal legal risks, supporting a high likelihood of deal closure. I expect the deal to close between ...
Greetings and welcome to the iCAD Incorporated Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode, and a question-and-answer session ...
Icad (ICAD) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.09 per share a year ago. These figures are adjusted ...
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of ...
CHICAGO--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, ...
Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA CHICAGO--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) ,an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback